Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma — Stella

Home/Retinoblastoma/

View on ClinicalTrials.gov

Recruiting

Back to Retinoblastoma trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong

Key details

Phase

Large-scale testing

Sponsor

Sun Yat-sen University

Enrollment target

~500 participants

Started

November 2020

Primary completion

December 2030

Last updated October 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.